Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease

被引:10
|
作者
Babulal, Ganesh M. [1 ,2 ,3 ,4 ]
Chen, Ling [5 ]
Doherty, Jason M. [1 ]
Murphy, Samantha A. [1 ]
Johnson, Ann M. [6 ]
Roe, Catherine M. [1 ]
机构
[1] Washington Univ, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Inst Publ Hlth, St Louis, MO 63110 USA
[3] Univ Johannesburg, Fac Humanities, Dept Psychol, Johannesburg, South Africa
[4] George Washington Univ, Sch Med & Hlth Sci, Dept Clin Res & Leadership, Washington, DC 20052 USA
[5] Washington Univ, Div Biostat, St Louis, MO 63110 USA
[6] Washington Univ, Ctr Clin Studies, St Louis, MO 63110 USA
关键词
Alzheimer's disease; anger; anxiety; biomarkers; cerebrospinal fluid; older adults; MILD BEHAVIORAL IMPAIRMENT; COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; OLDER-ADULTS; DEMENTIA; TAU; NEURODEGENERATION; PREVALENCE; PROFILE; DECLINE;
D O I
10.3233/JAD-215708
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) studies in cognitively normal (CN) older adults age >= 65 suggest depression is associated with molecular biomarkers (imaging and cerebrospinal fluid [CSF]). This study used linear mixed models (covariance pattern model) to assess whether baseline CSF biomarkers (A beta(42)/A beta(40), t-Tau/A beta(42) , p-Tau/A beta(42)) predicted changes in non-depressed mood states in CN older adults (N= 248), with an average of three follow-up years. Participants with higher levels of CSF biomarkers developed more anger, anxiety, and fatigue over time compared to those with more normal levels. Non-depressed mood states in preclinical AD may be a prodrome for neuropsychiatric symptoms in symptomatic AD.
引用
收藏
页码:141 / 148
页数:8
相关论文
共 50 条
  • [41] Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson's disease
    Hall, S.
    Surova, Y.
    Ohrfelt, A.
    Blennow, K.
    Zetterberg, H.
    Hansson, O.
    MOVEMENT DISORDERS, 2016, 31 : S240 - S240
  • [42] Cerebrospinal fluid biomarkers in Huntington's disease - a longitudinal study
    Niemela, V.
    Sundblom, J.
    Landtblom, A. -M.
    Herman, S.
    Kultema, K.
    Nyholm, D.
    Blennow, K.
    MOVEMENT DISORDERS, 2017, 32
  • [43] Longitudinal Changes of CSF Biomarkers in Alzheimer's Disease
    Seppala, Toni T.
    Koivisto, Anne M.
    Hartikainen, Paivi
    Helisalmi, Seppo
    Soininen, Hilkka
    Herukka, Sanna-Kaisa
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (04) : 583 - 594
  • [44] The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease
    Li, X.
    Li, T. -Q.
    Andreasen, N.
    Wiberg, M. K.
    Westman, E.
    Wahlund, L. -O.
    JOURNAL OF INTERNAL MEDICINE, 2014, 275 (04) : 418 - 427
  • [45] Vascular risk factors are associated with longitudinal changes in cerebrospinal fluid tau markers and cognition in preclinical Alzheimer's disease
    Bos, Isabelle
    Vos, Stephanie J. B.
    Schindler, Suzanne E.
    Hassenstab, Jason
    Xiong, Chengjie
    Grant, Elizabeth
    Verhey, Frans
    Morris, John C.
    Visser, Pieter Jelle
    Fagan, Anne M.
    ALZHEIMERS & DEMENTIA, 2019, 15 (09) : 1149 - 1159
  • [46] Longitudinal Stability Evaluation of Biomarkers and Their Correlation in Cerebrospinal Fluid and Plasma from Patients with Alzheimer's Disease
    Hoglund, Kina
    Bogstedt, Anna
    Fabre, Susanne
    Aziz, Ali
    Annas, Peter
    Basun, Hans
    Minthon, Lennart
    Lannfelt, Lars
    Blennow, Kaj
    Andreasen, Niels
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 32 (04) : 939 - 947
  • [47] Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study
    Liu, Guodong
    Liu, Chaoqiang
    Qiu, Anqi
    HUMAN BRAIN MAPPING, 2021, 42 (09) : 2931 - 2940
  • [48] Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
    Blennow, Kaj
    Hampel, Harald
    Weiner, Michael
    Zetterberg, Henrik
    NATURE REVIEWS NEUROLOGY, 2010, 6 (03) : 131 - 144
  • [49] Cerebrospinal fluid biomarkers in the evaluation of Alzheimer disease
    Verbeek, Marcel M.
    Rikkert, Marcel G. M. Olde
    CLINICAL CHEMISTRY, 2008, 54 (10) : 1589 - 1591
  • [50] Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
    Kaj Blennow
    Harald Hampel
    Michael Weiner
    Henrik Zetterberg
    Nature Reviews Neurology, 2010, 6 : 131 - 144